Goldman Sachs Group Inc. Sells 250,971 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Goldman Sachs Group Inc. decreased its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 15.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,397,000 shares of the company’s stock after selling 250,971 shares during the quarter. Goldman Sachs Group Inc. owned 26.92% of VanEck Pharmaceutical ETF worth $113,669,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of PPH. Steward Partners Investment Advisory LLC boosted its stake in VanEck Pharmaceutical ETF by 2.6% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 7,296 shares of the company’s stock valued at $594,000 after purchasing an additional 185 shares during the last quarter. Allworth Financial LP purchased a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth approximately $28,000. WT Wealth Management raised its holdings in shares of VanEck Pharmaceutical ETF by 1.5% during the 3rd quarter. WT Wealth Management now owns 35,458 shares of the company’s stock worth $2,832,000 after acquiring an additional 530 shares in the last quarter. Cary Street Partners Investment Advisory LLC purchased a new stake in shares of VanEck Pharmaceutical ETF during the 3rd quarter valued at about $60,000. Finally, CoreFirst Bank & Trust purchased a new stake in VanEck Pharmaceutical ETF during the 3rd quarter valued at $76,000.

VanEck Pharmaceutical ETF Stock Down 0.3 %

VanEck Pharmaceutical ETF stock traded down $0.25 during midday trading on Friday, reaching $91.68. The stock had a trading volume of 227,902 shares, compared to its average volume of 140,710. VanEck Pharmaceutical ETF has a 52-week low of $74.05 and a 52-week high of $92.97. The firm has a market cap of $544.58 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. The company has a fifty day moving average of $88.83 and a 200 day moving average of $86.73.

VanEck Pharmaceutical ETF Announces Dividend

The company also recently declared a dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, April 2nd were paid a dividend of $0.5328 per share. The ex-dividend date was Monday, April 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.